"Pemphigoid, Bullous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis.
| Descriptor ID |
D010391
|
| MeSH Number(s) |
C17.800.865.690 C20.111.730
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pemphigoid, Bullous".
Below are MeSH descriptors whose meaning is more specific than "Pemphigoid, Bullous".
This graph shows the total number of publications written about "Pemphigoid, Bullous" by people in this website by year, and whether "Pemphigoid, Bullous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 1 | 2 |
| 2000 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pemphigoid, Bullous" by people in Profiles.
-
Gandarillas S, Berger A, Stephenson R, Mehregan D, Dasgeb B. Enriched class II HLA inherence in patients with checkpoint inhibitor-associated bullous pemphigoid. Int J Dermatol. 2025 Feb; 64(2):399-401.
-
Samuel R, Garg V, Gaspari AA. Bullous Pemphigoid Triggered by a Titanium-Containing Knee Implant. Dermatitis. 2022 May-Jun 01; 33(3):179-180.
-
Brennan M, Baldissano M, King L, Gaspari AA. Successful Use of Rituximab and Intravenous Gamma Globulin to Treat Checkpoint Inhibitor- Induced Severe Lichen Planus Pemphigoides. Skinmed. 2020; 18(4):246-249.
-
Wolf R, Parish JL, Parish LC. The rash that presents as target lesions. Clin Dermatol. 2019 Mar - Apr; 37(2):148-158.
-
Abdul Salim S, Thomas L, Quorles A, Hamrahian SM, F?l?p T. New diagnosis of bullous pemphigoid after withdrawal of immunosuppressive therapy in a failed renal transplant recipient on hemodialysis. Hemodial Int. 2018 04; 22(2):E26-E32.
-
Tuchinda P, Ritchie S, Gaspari AA. Bullous pemphigoid treated with intravenous immunoglobulin. Cutis. 2014 May; 93(5):264-8.
-
Kupetsky EA, Rincon F. The prevalence of systemic diseases associated with dermatoses and stroke in the United States: a cross-sectional study. Dermatology. 2013; 227(4):330-7.
-
P?rez A, Almaani N, Stefanato CM, BhogaL B, Groves RW, Mellerio JE, McGrath JA. Bullous pemphigoid in a patient with suspected non-Herlitz junctional epidermolysis bullosa. Clin Exp Dermatol. 2010 Dec; 35(8):881-4.
-
Iwamoto S, Iwamoto AT, Cha J, Clark T, Lu M, Breen C, Bhawan J, Falanga V. The utility of the DNA microarray scanner to simplify the immunofluorescence evaluation of autoimmune bullous diseases. Am J Dermatopathol. 2009 May; 31(3):218-22.
-
Metz BJ, Ruggeri SY, Hsu S, Reed JA, Ghohestani AS, Uitto J, Ghohestani RF. Linear IgA dermatosis with IgA and IgG autoantibodies to the 180 kDa bullous pemphigoid antigen (BP180): evidence for a distinct subtype. Int J Dermatol. 2004 Jun; 43(6):443-6.